IGENE Biotechnology, Inc. engages in the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company is headquartered in Columbia, Maryland and currently employs 18 full-time employees. The firm develops, produces and markets specialty biochemical products. The company is a supplier of natural astaxanthin, a nutrient in different feed applications and a source of pigment for coloring farmed salmon species. Igene provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors. The company also provides analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. Within animal nutrition, the Company focus is to deliver astaxanthin to the fish feed market.
IGNE stock price ended at $0 on 星期四, after rising NaN%
On the latest trading day Aug 21, 2025, the stock price of IGNE rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 296.1K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 300.1K shares were traded, equating to a market value of approximately --.